• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
hearing audio waves
Pharma

Regeneron ushers in new era with inaugural gene therapy approval

The FDA today approved the company’s Otarmeni, the first gene therapy for a rare genetic form of hearing loss that affects about 50 newborns per year.
Darren Incorvaia Apr 23, 2026 3:22pm
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags in Week 2

Apr 24, 2026 4:10pm
Brain Cancerjpg

Why Molecular Testing Is Key to Brain Cancer Diagnosis

Brought to you by Jazz Pharmaceuticals
Roche

UPDATED: Roche Q1 earnings see hits and misses across key products

Apr 24, 2026 1:55pm
two red lights

AbbVie, Grace Therapeutics receive manufacturing-related CRLs

Apr 24, 2026 11:37am
European Medicines Agency

With EU backing, Sanofi gains long-awaited win for tolebrutinib

Apr 24, 2026 11:30am
More News

Daiichi delays annual report amid ‘rapidly changing’ conditions

Apr 24, 2026 10:40am

Travere’s launchpad positions Filspari for fast rollout: analyst

Apr 24, 2026 10:06am

Can Trump’s UK deal become a drug pricing model?

Apr 24, 2026 9:00am

Pfizer drafts Fernando Mendoza as face of its cancer campaign

Apr 24, 2026 8:58am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings